Research study Program year 2025 Source: CMS Open Payments

IST- Tolerance Combination Dose-Carfilzomide-IV

Research payments

$10,727,248

154 payments

Through program year 2025, $10,727,248 in research payments was reported against IST- Tolerance Combination Dose-Carfilzomide-IV, across 154 payments.

Paid by (largest first)
Sanofi US Services Inc.; Genzyme Corporation
ClinicalTrials.gov
No trial number was reported for this study

By program year

4 rows
Year Kind Amount Payments
2025 Research $2,440,481 33
2024 Research $2,946,072 43
2023 Research $2,712,403 35
2022 Research $2,628,292 43

Breakdown

Who paid Research payments · program years 2022–2025
  1. Sanofi US Services Inc. $9,491,483 132 payments
  2. Genzyme Corporation $1,235,765 22 payments
Who received the money Research payments · program years 2022–2025
  1. John Theurer Cancer Center At Hackensack Umc Organisation paid for research $3,325,280 43 payments
  2. Ucsfmedical Center Organisation paid for research $1,235,765 22 payments
  3. John Theurer Cancer Center Organisation paid for research $1,044,302 12 payments
  4. Sarah Cannon Research Institute,LLC Organisation paid for research $885,572 12 payments
  5. Tennessee Oncology, Pllc Organisation paid for research $662,956 6 payments
  6. Multiple Myelana Research Foundation Organisation paid for research $638,577 2 payments
  7. Tennessee Oncology Organisation paid for research $530,372 8 payments
  8. Sarah Cannon Research Institute Organisation paid for research $499,791 7 payments
  9. Langley Porter Psychiatric Hospital Teaching hospital · CA $388,046 10 payments
  10. UCSF School Of Pharmacy Organisation paid for research $352,793 8 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record